Email Updates

Search form

You are here

Webinar & Meeting Reports

  • April 20, 2016

    Presenters spoke about PrEP’s use and provision in countries that haven’t yet approved it, or who are in the early days post approval. Among others, these presenters from Thailand, South Africa, England, Peru, Mexico and the United States took on the following questions and more...

  • April 6, 2016

    Community Perspectives from CROI 2016 was the second in a webinar series that offers women living with HIV capacity building and training on HIV disease and treatment advocacy. During this webinar, participants received an overview of HIV science by several speakers.

  • March 24, 2016

    Heard about a “tail” for long-acting injectables and want to know more? Interested in the timeline for when people with HIV might have injectable drug options for treatment? Wondering how people felt about getting an injection for PrEP? David Margolis (ViiV Healthcare) and Marty Markowitz (Aaron Diamond AIDS Research Center) spoke about long-acting injectable antiretrovirals for treatment and prevention.

  • March 17, 2016

    John Mascola of the NIH Vaccine Research Center spoke about harnessing antibodies for HIV prevention and treatment.

  • March 11, 2016

    The US women and PrEP Working Group held a webinar on the state of the science and implementation of PrEP for women in the US.

  • March 1, 2016

    In the first webinar in our post-CROI webinar series, Jared Baeten (MTN) and Zeda Rosenberg (IPM) spoke about the dapivirine ring trial results announced at the conference and fielded questions from webinar participants.

  • February 22, 2016 to February 25, 2016

    The annual Conference on Retroviruses and Opportunistic Infections (CROI) took place from February 22 to 25 in Boston. Read on for news and materials from the conference and information on our post-CROI webinar series.

  • December 7, 2015

    Mirroring the need for intersectionality and inclusivity in the fight to end HIV/AIDS, the People’s Mobilization on the National HIV/AIDS Strategy Counter Conference is a community-built space that aims to empower constituencies most impacted by HIV to be in control of the dialogue. The Counter Conference happened in parallel with the National HIV Prevention Conference (NHPC) as an alternative and accessible space for those who cannot attend the larger NHPC.

  • December 6, 2015

    The National HIV Prevention Conference allowed for in-person collaboration between researchers and program personnel planning and implementing HIV prevention and care programs. The conference brought together more than 3,000 individuals who are working to stop the domestic spread of HIV. It provided an opportunity to continue refining, improving and strengthening our nation’s response to HIV.

  • December 3, 2015

    The Rockefeller University invited people to learn about promising new approaches to treat and prevent HIV. Attendees heard about ongoing research with broadly neutralizing antibodies, components of the body’s immune system that can be harnessed to attack HIV, and perspectives from scientists, doctors, HIV advocates and volunteers in clinical trials about their experiences with HIV research.

Pages